Why Ramsay Health Care Limited (ASX:RHC) is making a $1.3 billion bet on Europe

The Ramsay Health Care Limited (ASX: RHC) share price is up today on the back of a deal to acquire Capio AB.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Investors in Ramsay Health Care Limited Fully Paid Ord. Shrs (ASX: RHC) shares have suffered a tough year with the stock down around 18% over the past 12 months after the hospital operator revealed weaker-than-expected profit growth in financial year 2018.

Also acting as a drag on Ramsay's share price is the group's guidance for earnings per share growth "up to 2%" in financial year 2019 that equates to core EBITDA growth of between 4% to 6% according to the group.

Ramsay's CEO Craig Mcnally attributed the soft guidance to "challenging circumstances" in the UK as the public health service fed less business to Ramsay's operations in that country, while a lower tariff environment in France also hurt Ramsay's operations in financial year 2018.

However, it seems Ramsay's management has not been put off by the tough funding environments in Europe with the group today announcing that it will almost certainly go ahead with its $1.3 billion acquisition of Sweden-based integrated healthcare group Capio AB.

This is after 96% of Capio's shareholders accepted Ramsay's subsidiary's improved offer of SEK (Swedish kroner) 58 per share. The original offer stood at SEK48.5 per share in cash.

Ramsay reports that the deal will be a win for investors as it will be able to extract EUR20 million in synergies (cost savings, etc) from the combined groups within 2-3 years, with core earnings per share accretion expected within 2-3 years.

While Ramsay's share price has fallen heavily over the past year, over the long term it has been an excellent performer for investors. In fact, it has grown five times in value from a price of around $11 at the start of 2010 to close to $55 today.

The long-term success is because Ramsay has several reasonably reliable growth strategies; including acquisitions (as with Capio AB), brownfield expansions (e.g. developing capacity at existing operations), greenfield expansions (buying land and constructing new operations), partnering with the public sector, and organic growth.

Underpinning all of this growth is a rising demand for healthcare services as populations age and living standards rise.

As such Ramsay is one of a number of successful operators in the healthcare sector that also includes Primary Health Care Limited (ASX: PRY), Medibank Private Ltd (ASX: MPL) and Healthscope Ltd (ASX: HSO).

Investors then shouldn't write Ramsay off just because its share price has been in reverse for the past 12 months.

Motley Fool contributor Yulia Mosaleva owns shares in Ramsay Health Care Limited. The Motley Fool Australia has recommended Ramsay Health Care Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

Cropped shot of an attractive young female scientist working on her computer in the laboratory.
Healthcare Shares

CSL share price leaping higher amid $1.9 billion funding news

ASX 200 investors are bidding up the CSL share price on Wednesday.

Read more »

Two happy scientists analysing test results.
Healthcare Shares

Mesoblast share price rockets 36% on breaking FDA news

ASX investors are sending the Mesoblast share price soaring following promising FDA news.

Read more »

a doctor in white coat and stethoscope stands in front of a building holding an electronic device in his hands.
Healthcare Shares

Guess which ASX 200 healthcare share is jumping 7% on a guidance update

This healthcare share is performing better than expected in FY 2024.

Read more »

a biomedical researcher sits at his desk with his hand on his chin, thinking and giving a small smile with a microscope next to him and an array of test tubes and beackers behind him on shelves in a well-lit bright office.
Earnings Results

Chemist Warehouse merger target Sigma reports 149% FY24 profit jump

This could be the last set of results from Sigma as we know it if its merger is approved.

Read more »

Cropped shot of an attractive young female scientist working on her computer in the laboratory.
Healthcare Shares

1 ASX healthcare stock that looks severely undervalued

I think this stock looks too cheap to miss.

Read more »

Stethoscope with a piggy bank and hundred dollar notes.
Healthcare Shares

Own Medibank shares? Here's why it's a rewarding day for you

Shareholders are getting a healthy boost today.

Read more »

Health professional looking at a laptop.
Healthcare Shares

Are CSL shares a must-buy in March?

Let's see what analysts are saying about this high-quality company.

Read more »

A woman jumps for joy with a rocket drawn on the wall behind her.
Healthcare Shares

This ASX healthcare stock is up 72% on FDA news and 'historic moment'

Huge gains are been recorded by this stock on Tuesday. But why?

Read more »